The relationship between medication beliefs, patient activation, and self-rated health in patients taking oral anticancer agents
- PMID: 38904864
- DOI: 10.1007/s00520-024-08672-3
The relationship between medication beliefs, patient activation, and self-rated health in patients taking oral anticancer agents
Abstract
Purpose: Patients on oral anticancer agent (OAA) therapies have the autonomy to manage their cancer treatments in home settings. However, patients may not have adequate knowledge, confidence, or ability to effectively manage OAA-related consequences, which can significantly impact their treatment and health outcomes. This study aims to identify the associations between medication beliefs, patient activation, and self-rated health (SRH) among oncology patients taking OAAs and explore the potential mediation effects of patient activation on the relationship between medication beliefs and SRH.
Methods: A secondary data analysis was conducted on cross-sectional data from 114 patients who were diagnosed with breast, colorectal, lung, or prostate cancer. Patients completed a self-reported survey including items of SRH, Beliefs about Medicines Questionnaire (BMQ), and Patient Activation Measure (PAM-13). Descriptive statistics, bivariate correlation, hierarchical multiple linear regression, and mediation analysis were conducted.
Results: The results indicate that patients taking OAAs have ambivalent attitudes toward medication. Both medication necessity (r = - 0.27) and concerns (r = - 0.21) were negatively associated with SRH, while patient activation was positively associated with SRH (r = 0.38). Patient activation had a negative association with medication concerns (r = - 0.36) and fully mediated the relationship between medication concerns and SRH in patients taking OAAs (indirect effect = - 0.154, 95% confidence interval, - 0.276 to - 0.060).
Conclusion: The findings highlight the significance of activating patients to better understand and manage their OAAs. It is crucial for oncology professionals to provide multifaceted interventions to promote patient activation with an effort to mitigate the negative impact of medication beliefs on patient-perceived health outcomes.
Keywords: Medication beliefs; Oral anticancer agents; Patient activation; Self-rated health.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
How adverse events and permanent medication stoppages affect changes in patients' beliefs about oral antineoplastic agents.Support Care Cancer. 2020 Jun;28(6):2589-2596. doi: 10.1007/s00520-019-05073-9. Epub 2019 Sep 16. Support Care Cancer. 2020. PMID: 31529159
-
The association between patients' perceived continuity of care and beliefs about oral anticancer treatment.Support Care Cancer. 2019 Sep;27(9):3545-3553. doi: 10.1007/s00520-019-04668-6. Epub 2019 Jan 28. Support Care Cancer. 2019. PMID: 30689046
-
Subjective health, general medicine beliefs and social desirability response among older hospital outpatients in Hong Kong.Int J Pharm Pract. 2020 Oct;28(5):498-505. doi: 10.1111/ijpp.12628. Epub 2020 Apr 27. Int J Pharm Pract. 2020. PMID: 32342593
-
A Concept Analysis of Oral Anticancer Agent Self-management.Cancer Nurs. 2022 Mar-Apr 01;45(2):E374-E387. doi: 10.1097/NCC.0000000000000934. Cancer Nurs. 2022. PMID: 33654013 Free PMC article. Review.
-
Factors Associated With Medication Beliefs in Patients With Cancer: An Integrative Review.Oncol Nurs Forum. 2018 Jul 2;45(4):508-526. doi: 10.1188/18.ONF.508-526. Oncol Nurs Forum. 2018. PMID: 29947359 Review.
References
-
- Salgado TM, Mackler E, Severson JA, Lindsay J, Batra P, Petersen L, Farris KB (2017) The relationship between patient activation, confidence to self-manage side effects, and adherence to oral oncolytics: a pilot study with Michigan oncology practices. Support Care Cancer 25:1797–1807. https://doi.org/10.1007/s00520-017-3584-0 - DOI - PubMed
-
- Doshi JA, Jahnke J, Raman S, Puckett JT, Brown VT, Ward MA, Li P, Manz CR (2021) Treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries. J Manag Care Spec Pharm 27:1457–1468. https://doi.org/10.18553/jmcp.2021.27.10.1457 - DOI - PubMed
-
- Dechanont S, Maphanta S, Butthum B, Kongkaew C (2014) Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf 23:489–497. https://doi.org/10.1002/pds.3592 - DOI - PubMed
-
- Tipton JM (2015) Overview of the challenges related to oral agents for cancer and their impact on adherence. Clin J Oncol Nurs 19:37–40. https://doi.org/10.1188/15.S1.Cjon.37-40 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
